The influence of acetylator phenotype on the outcome of treatment with phenelzine, in a clinical trial.
D000107:Acetylation; D002986:Clinical Trials as Topic; D006801:Humans; D007700:Kinetics; D009497:Neurotic Disorders / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D010624:Phenelzine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D010641:Phenotype; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D013997:Time Factors
D010919:Placebos; D010624:Phenelzine